Remix Therapeutics

Our Science
About Us
Join Us
News
Clinical Trials

Our Science
About Us
Join Us
News
Clinical Trials
Contact

Advisor Category: Advisors

Ryan Corcoran

Benoit Chabot

Juan Valcarcel

Steve Kelsey

Aaron Hoskins

Zaven Kaprielian

Christopher Burge

Search

Recent Posts

Remix Therapeutics™ to Present at 46th Annual Canaccord Genuity Growth Conference
Download the latest corporate deck
Remix Therapeutics™ to Present at AACR Drug Discovery and Development Conference
Passage Bio and Remix Therapeutics™ Announce Merger Agreement
Remix Therapeutics™ Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026

Recent Comments

No comments to show.

Archives

Categories

News
Presentation
Press Release
Publication

Remix Therapeutics

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

Our Science
About Us
Join Us
News
Clinical Trials
Contact

100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901

© 2023 Remix Therapeutics, Inc. All Rights Reserved